Mawer Investment Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,373
Closed -$8.67M 105
2024
Q3
$8.67M Sell
27,373
-10,929
-29% -$3.89M 0.04% 94
2024
Q2
$14.3M Buy
38,302
+14,213
+59% +$4.8M 0.07% 80
2024
Q1
$8.35M Buy
24,089
+12,066
+100% +$4.57M 0.04% 86
2023
Q4
$5.5M Buy
12,023
+985
+9% +$486K 0.03% 80
2023
Q3
$5.37M Buy
11,038
+1,028
+10% +$483K 0.03% 79
2023
Q2
$4.48M Buy
10,010
+2,923
+41% +$1.47M 0.02% 78
2023
Q1
$3.44M Buy
7,087
+1,077
+18% +$532K 0.02% 82
2022
Q4
$3.08M Buy
6,010
+2,493
+71% +$1.31M 0.02% 86
2022
Q3
$1.71M Buy
+3,517
New +$1.71M 0.01% 88

Other funds holding HUM

Mawer Investment Management's HUM Position: Q4 2024 in Review

Mawer Investment Management sold out of Humana (HUM) in Q4 2024, closing a stake of 27,373 shares — an estimated $8.67M sold.

Mawer Investment Management first reported a position in HUM in Q3 2022 and held it in 9 quarters. The position peaked at $14.3M in Q2 2024. 876 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Mawer Investment Management reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Mawer Investment Management sold 27,373 Humana shares in Q4 2024, an estimated $8.67M.
  • Mawer Investment Management first reported a position in Humana in Q3 2022 and held it in 9 quarters.
  • Mawer Investment Management's Humana position peaked at $14.3M in Q2 2024.
  • 876 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Mawer Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.